On 20 July 2010, the European Commission Directorate General for Research published the 2011 Health Work Programme of the Seventh Framework Programme for research and technological development (FP7)
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide... Read more
EASL Members: Request your free copy of the EASL history book
Management of chronic hepatitis B

CPGs define the use of diagnostic, therapeutic and preventive modalities, including non-invasive and invasive procedures, in the management of patients with various liver diseases. They are intended to assist physicians and other healthcare providers as well as patients and interested individuals in the clinical decision making process by describing a range of generally accepted approaches for the diagnosis, treatment and prevention of specific liver diseases. CPGs have to be distinguished from consensus statements and position papers.

  • A consensus statement reports the conclusions of a consensus conference.
  • A position paper reflects the opinions of experts.

Future guidelines include:

  • Management of Hepatocellular Carcinoma
  • Management of Hepatitis C Virus Infection
  • Management of Alcoholic Liver Disease
  • Management of Acute Liver Failure
  • Management of Wilson's Disease